Rosuvastatin Calcium Tablet
Product Images NDC 68788-4047

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68788-4047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin Calcium Tablets 20mg (Rosuvastatin Tablets 20mg 90s Bottle Label)

This is information regarding Rosuvastatin Calcium Tablets, a generic for Crestor, containing 20mg of active ingredient. The tablets are film-coated and should be stored between 20°C to 25°C (68°F to 77°F). The manufacturer is Umedica Laboratories Pvt. Ltd. Each tablet is round, pink, and imprinted with R20. The medication is prescription-only, and caution is advised against giving it to anyone other than the prescribed patient. The tablets come in a specified package size with an expiration date. It is recommended to keep the medication away from children and protect it from moisture.*

FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

This text provides information about a medical study with a hazard ratio of 0.56 and a 95% confidence interval of 0.46-0.69. The p-value is significant at less than 0.001. It also includes data on cumulative incidence in percentages for two groups, RSV and Placebo, with the number at risk over different time periods (Years). The information suggests a comparison between the effects of RSV and Placebo on a particular outcome.*

FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

This is a table showing the number of events for patients taking Rosuva 20 mg versus Placebo 20 mg. The data includes the number of events, event rates per 1000-patient years, hazard ratio with 95% confidence intervals, and p-values for various endpoints such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, and arterial revascularization. The results suggest that Rosuva 20 mg may be associated with a lower risk of major cardiovascular events compared to placebo.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

This text provides a list of different statin medications and their corresponding doses in milligrams. The statins mentioned are CRESTOR, Atorvastatin, Simvastatin, and Pravastatin, with dose variations of 10, 20, 40, and 80 mg. It appears to be a reference for LDL-C (low-density lipoprotein cholesterol) and percentage change calculations.*

FDA Label Image

Logo (Rosuvastatin Tablets Logo)

FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.